angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with leucine-beta-naphthylamide in 1 studies
| Studies (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Trials (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Recent Studies (post-2010) (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Studies (leucine-beta-naphthylamide) | Trials (leucine-beta-naphthylamide) | Recent Studies (post-2010) (leucine-beta-naphthylamide) |
|---|---|---|---|---|---|
| 311 | 5 | 64 | 17 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albiston, AL; Chai, SY; Lew, RA; McDowall, SG; Mustafa, T; Ye, S | 1 |
1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and leucine-beta-naphthylamide
| Article | Year |
|---|---|
Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity | 2003 |